EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Acute Lung Injury and the NLRP3 Inflammasome

Wanjun Gu, Qi Zeng, Xin Wang, Huthaifa Jasem, Ling Ma

Journal of Inflammation Research · 2024-06 · Volume 17 · 3801-3813

DOI: 10.2147/jir.s464838 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2024-06. Verfasst von Wanjun Gu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, People's Republic of China. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lung injury (ALI) manifests through harm to the capillary endothelium and alveolar epithelial cells, arising from a multitude of factors, leading to scattered interstitial alterations, pulmonary edema, and subsequent acute hypoxic respiratory insufficiency. Acute lung injury (ALI), along with its more serious counterpart, acute respiratory distress syndrome (ARDS), carry a fatality rate that hovers around 30-40%. Its principal pathological characteristic lies in the unchecked inflammatory reaction. Currently, the main strategies for treating ALI are alleviation of inflammation and prevention of respiratory failure. Concerning the etiology of ALI, NLRP3 Inflammasome is essential to the body's innate immune response. The composition of this inflammasome complex includes NLRP3, the pyroptosis mediator ASC, and pro-caspase-1. Recent research has reported that the inflammatory response centered on NLRP3 inflammasomes plays a key part in inflammation in ALI, and may hence be a prospective candidate for therapeutic intervention. In the review, we present an overview of the ailment characteristics of acute lung injury along with the constitution and operation of the NLRP3 inflammasome within this framework. We also explore therapeutic strategies targeting the NLRP3 inflammasome to combat acute lung injury.

Schlagwörter

Stichwörter der Autor:innen

IL-18IL-1βNLRP3 inflammasomeacute lung injurycaspase-1

Autor:innen und Institutionen

  • Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, People's Republic of China.

Zitieren

APA

Gu, W., Zeng, Q., Wang, X., Jasem, H., & Ma, L. (2024). Acute Lung Injury and the NLRP3 Inflammasome. Journal of Inflammation Research, Volume 17, 3801-3813. https://doi.org/10.2147/jir.s464838

Vancouver

Gu W, Zeng Q, Wang X, Jasem H, Ma L. Acute Lung Injury and the NLRP3 Inflammasome. Journal of Inflammation Research. 2024;Volume 17:3801-3813. doi:10.2147/jir.s464838

BibTeX
@article{Gu2024,
  author = {Gu, Wanjun and Zeng, Qi and Wang, Xin and Jasem, Huthaifa and Ma, Ling},
  title = {Acute Lung Injury and the NLRP3 Inflammasome},
  journal = {Journal of Inflammation Research},
  year = {2024},
  volume = {Volume 17},
  pages = {3801--3813},
  doi = {10.2147/jir.s464838}
}
Kostenlos starten →